Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage
β Scribed by Eandi, M. ;Viano, I. ;Di Nola, F. ;Leone, L. ;Genazzani, E.
- Publisher
- Springer-Verlag
- Year
- 1983
- Weight
- 397 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0722-2211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objectives: To determine the effect of reduced hepatic function on the pharmacokinetics of minoxidil. The pharmacokinetics of antipyrine, lorazepam, and indocyanine green were included as indicators of hepatic function. Methods: Eight mild cirrhotics and eight healthy subjects received antipyrine (p
The pharmacokinetics of the beta 1-selective adrenergic antagonist (R,S)-celiprolol has been studied after oral administration of 200 mg celiprolol-HCl to 8 healthy volunteers and 8 patients with various degrees of impaired renal function. No significant difference was found between the two enantiom
The pharmacokinetics of diltiazem were studied in seven patients with chronic renal failure (CRF) not requiring dialysis and in three healthy volunteers after a rapid i.v. infusion of 20mg. Mean plasma concentrations at the end of infusion were 3.15 times higher in patients with CRF than in healthy